VaccinexVCNX
13F holders, Q2 2024 (June 30)11holders −1
1new positions
2sold out
1famous investor
$5.61avg. 13F price*
At the end of Q2 2024, 11 institutions reported holding Vaccinex Inc. (VCNX) in their 13F filings, down 1 from Q1 2024. 1 opened new positions and 2 sold out. The largest holders were Point72 Asset Management ($756K), Armistice Capital, LLC ($610K) and AIGH Capital Management LLC ($424K). One famous investor held it Steve Cohen (0.0% of Point72 Asset Management's portfolio).
- Company
- Vaccinex Inc.
- CUSIP
- 918640301
- Latest filing quarter
- Q4 2024
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $52 |
| Exits | 2 | $2K |
All 13F filers, Q1 2024 → Q2 2024: 50,880 shares bought and 51,345 shares sold, net −465 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 11 holders
| Point72 Asset Management | 0.00% | No change | 116,546 | $756K |
| Armistice Capital, LLC | 0.02% | Reduce -35.2% | 94,000 | $610K |
| AIGH Capital Management LLC | 0.21% | Add +86.7% | 108,958 | $424K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +26.7% | 1,324 | $9K |
| Morgan Stanley | 0.00% | No change | 1,113 | $7K |
| Group One Trading LLC | 0.00% | No change | 67 | $438 |
| Osaic Holdings, Inc. | 0.00% | No change | 53 | $343 |
| Bank of America Corp. | 0.00% | New | 8 | $52 |
| Wells Fargo & Company | 0.00% | Reduce -75.0% | 2 | $13 |
| Royal Bank of Canada | 0.00% | No change | 39 | $0 |
| Capital Advisors, Ltd. LLC | 0.00% | Reduce -76.9% | 3 | $0 |
"% of holder's portfolio" is VCNX's weight in each manager's 13F, not the share of Vaccinex Inc. the manager owns.